Literature DB >> 13768326

Intrarectal treatment of 100 cases of ulcerative colitis with prednisolone-21-phosphate enemata.

S G MATTS.   

Abstract

Entities:  

Keywords:  COLITIS, ULCERATIVE/therapy; ENEMA; PREDNISOLONE/related compounds

Mesh:

Substances:

Year:  1961        PMID: 13768326      PMCID: PMC1952985          DOI: 10.1136/bmj.1.5220.165

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium; a controlled trial employing restricted sequential analysis.

Authors:  G WATKINSON
Journal:  Br Med J       Date:  1958-11-01

2.  A comparative trial of salazopyrin, prednisone and hydrocortisone retention enemata in the out-patient treatment of left-sided colitis. Preliminary report.

Authors:  J E LENNARD-JONES; A J LONGMORE; F A JONES
Journal:  Proc R Soc Med       Date:  1960-08

3.  Treatment of ulcerative colitis with local hydrocortisone.

Authors:  S C TRUELOVE
Journal:  Br Med J       Date:  1956-12-01
  3 in total
  8 in total

Review 1.  THE CONTROLLED THERAPEUTIC TRIAL IN GASTROENTEROLOGY.

Authors:  S C TRUELOVE; R WRIGHT
Journal:  Am J Dig Dis       Date:  1964-01

2.  Rectal hydrocortisone for ulcerative colitis refractory to oral corticosteroids.

Authors:  L M HERSHENSON; M A HERSHENSON
Journal:  Am J Dig Dis       Date:  1961-06

3.  Retrograde spread of hydrocortisone containing foam given intrarectally in ulcerative colitis.

Authors:  M J Farthing; M D Rutland; M L Clark
Journal:  Br Med J       Date:  1979-10-06

4.  Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema.

Authors:  D A Lee; G M Taylor; V H James; G Walker
Journal:  Gut       Date:  1979-05       Impact factor: 23.059

Review 5.  Inflammatory bowel disease.

Authors:  G M Van Rosendaal
Journal:  CMAJ       Date:  1989-07-15       Impact factor: 8.262

6.  Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis.

Authors:  P B McIntyre; F A Macrae; L Berghouse; J English; J E Lennard-Jones
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

7.  Pharmaceutical characterization of corticosteroid suppository treatment for ulcerative colitis.

Authors:  S Sadahiro; Z Ito; T Iijima; M Noguchi; K Hosoi
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

8.  Rectally administered prednisolone--evidence for a predominantly local action.

Authors:  D A Lee; M Taylor; V H James; G Walker
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.